期刊文献+

氨基酸转运体L型氨基酸转运载体1在肿瘤中的研究进展 被引量:1

Progress on L -type amino acid transporter-1 in tumor
原文传递
导出
摘要 氨基酸转运体足介导氨基酸跨膜转运的膜蛋白。L型氨基酸转运载体1(LAT1)是L型氨基酸转运载体中的重要成员,主要负责转运大分子支链氨基酸和芳香族的中性氨基酸,包括一些必需氨基酸,如亮氨酸等。LAT1在恶性肿瘤中呈过度表达,能促进肿瘤细胞的增殖、侵袭、迁移和肿瘤血管的形成。LAT1在陕学、营养学、动物学等生命科学领域有着重要的研究意义。 Amino acid transporters are a kind of membrane protein, mediating amino acid transmembrane transport. L - type amino acid transporter 1 ( LAT1 ) is a member of the sodium - independent amino acid transport system L, and transports large branched -chain, aromatic neutral amino acid and essential amino acid, such as leu- cine. Overexpressed LATI can promote cell proliferation, invasion and metastasis and tumor angiogenesis in malignant tumor. LATI plays a significant role in physics, nutrition science and zoology. This paper focuses on the roles of LAT1 in tumor.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第2期550-552,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金(81072152) 湖北省自然科学基金(2015CFA027) 湖北省卫牛计生科研基金(WJ2015MA010)
关键词 氨基酸转运体 L型氨基酸转运载体1 肿瘤 Amino acid transporter L - type amino acid transporter 1 Ontology
  • 相关文献

参考文献14

  • 1Xu M, Sakamoto S, Matsushima J, et al. Up-regulation of LAT1 during antiandrogen therapy contributes to progression in prostate cancer cells [J]. J Uro1,2015, pii : S0022-5347 ( 15 ) 05395-1.
  • 2Yokobori Y, Toyoda M, Sakakura K, et al. (18 )F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcino- naa [ J ]. Acta Otolaryngol,2015,135 ( 5 ) :494-499.
  • 3Kaira K, Oriuchi N, Shimizu K, et al. Comparison of L-type amino acid transporter 1 expression and L-[ 3-18F ]-or-methyl tyrosine uptake in outcome of non-small cell lung cancer [ J]. Nucl Med Biol,2010,37 (8) :911-916.
  • 4Isoda A,Kaira K, Iwashina M, et al. Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma[ Jl. Cancer Sci,2014,105( 11 ) :1496-1502.
  • 5Wang Q, Bailey CG, Ng C, et al. Androgen receptor and nutrient signa- ling pathways coordinate the demand for increased amino acid trans- port during prostate cancer progression [ J ]. Cancer Res, 2011,71 (24) :7525-7536.
  • 6Toyoda M, Kaira K,Shino M ,et al. CD98 as a novel prognostic indica- tor for patients with stage III/IV hypopharyngeal squamous cell carci- noma[J]. Head Neck,2015,37( 11 ) :1569-1574.
  • 7Toyoda M, Kaira K, Ohshima Y, et al. Prognostic significance of ami- no-acid transporter expression (EATI ,ASCT2,and xCT) in surgically resected tongue cancer[J]. Br J Cancer,2014,110(10) :2506-2513.
  • 8Janpipatkul K, Suksen K, Borwornpinyo S, et al. Downtegulation of LAT1 expression suppresses cholangioeareinoma cell invasion and mi- gration [ J 1- Cell Signal,2014,26 ( 8 ) : 1668-1679.
  • 9Ikotun OF, Marquez BV, Huang C, et al. Imaging the L-type amino acid transporter-I (LAT1) with Zr-89 immuno PET[ J]. PLoS One, 2013,8(10) :e77476.
  • 10Rosi|io C, Nebout M, Inabert ~, et al. L-type amino-acid transporter 1 ( LAT1 ) : a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia [ J ]. Leukemia, 2014,29 ( 6 ) : 1253 -1266.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部